A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

NCT02431702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

337

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Psychotic Disorders

Interventions

DRUG: Aripiprazole
DRUG: Haloperidol
DRUG: Olanzapine
DRUG: Oral Paliperidone ER
DRUG: Perphenazine
DRUG: Quetiapine
DRUG: Oral Risperidone
DRUG: Paliperidone Palmitate Injection (PP1M)
DRUG: Paliperidone Palmitate Injection (PP3M)

Sponsor

Janssen Scientific Affairs, LLC